secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001193125-26-096565
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health receives Nasdaq delisting notice for bid price; plans to appeal
-----------------------------------------------------------------------------

- Nasdaq notice on March 5, 2026: bid price below $1.00 for 30 consecutive business days.
- Company ineligible for compliance period due to reverse stock split(s) in prior two years.
- Must request appeal by March 12, 2026; intent to timely appeal to Hearings Panel.
- Appeal request automatically stays suspension pending hearing outcome; no guarantee of relisting.
- Ticker JAGX trades on Nasdaq; delisting would occur if appeal fails.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526096565/0001193125-26-096565-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526096565/d62332d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-096565

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer